Histopathology revealed a grade 2 infiltrating ductal carcinoma, phenotype luminal-Her2, with positive estrogen and progesterone receptors and overexpression of human epidermal receptor 2 (Her2/neu) in tumor cells. Here, ERBB2 is linked to invasive ductal breast carcinoma.